Litcius/Paper detail

Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials

Christopher E. Brightling, Mina Gaga, Hiromasa Inoue, Jing Li, Jorge Máspero, Sally E. Wenzel, Samopriyo Maitra, David Lawrence, Florian Brockhaus, Thomas Lehmann, Caterina Brindicci, Barbara Knorr, Eugene R. Bleecker

2020The Lancet Respiratory Medicine96 citationsDOI

Topics & Concepts

MedicineAsthmaPlaceboInternal medicineSputumEosinophilPopulationClinical endpointClinical trialRandomized controlled trialPathologyTuberculosisEnvironmental healthAlternative medicineAsthma and respiratory diseasesDelphi Technique in ResearchChronic Obstructive Pulmonary Disease (COPD) Research